These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

907 related items for PubMed ID: 18840377

  • 1. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M.
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [Abstract] [Full Text] [Related]

  • 2. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [Abstract] [Full Text] [Related]

  • 3. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Delcò F, Egger R, Bauerfeind P, Beglinger C.
    Aliment Pharmacol Ther; 2005 Mar 01; 21(5):615-22. PubMed ID: 15740546
    [Abstract] [Full Text] [Related]

  • 4. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.
    Ann Pharmacother; 2007 Nov 01; 41(11):1761-9. PubMed ID: 17895328
    [Abstract] [Full Text] [Related]

  • 5. Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study.
    Armoiry X, Fagnani F, Benboubker L, Facon T, Fermand JP, Hulin C, Moreau P, Aulagner G.
    J Clin Pharm Ther; 2011 Feb 01; 36(1):19-26. PubMed ID: 21198717
    [Abstract] [Full Text] [Related]

  • 6. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P, Nordling S, Reimer J, Grabowski M, Persson U.
    Mov Disord; 2002 Nov 01; 17(6):1213-20. PubMed ID: 12465059
    [Abstract] [Full Text] [Related]

  • 7. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov 01; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 8. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Nov 01; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 9. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
    Kobelt-Nguyen G, Gerdtham UG, Alm A.
    J Glaucoma; 1998 Apr 01; 7(2):95-104. PubMed ID: 9559495
    [Abstract] [Full Text] [Related]

  • 10. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
    Stäbler W, Wagner B.
    Klin Padiatr; 2003 Apr 01; 215(3):179-84. PubMed ID: 12778360
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P.
    Int J Clin Pract; 2008 May 01; 62(5):708-16. PubMed ID: 18355236
    [Abstract] [Full Text] [Related]

  • 13. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.
    Dumont S, Jacobs P, Fassbender K, Anderson D, Turcotte V, Harel F.
    Palliat Med; 2009 Dec 01; 23(8):708-17. PubMed ID: 19837702
    [Abstract] [Full Text] [Related]

  • 14. A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma; a prospective randomised phase III study.
    van Agthoven M, Segeren CM, Buijt I, Uyl-de Groot CA, van der Holt B, Lokhorst HM, Sonneveld P.
    Eur J Cancer; 2004 May 01; 40(8):1159-69. PubMed ID: 15110879
    [Abstract] [Full Text] [Related]

  • 15. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L, Gower N, Spiro S, Rudd R, Stephens R, West P.
    Thorax; 2005 Jul 01; 60(7):564-9. PubMed ID: 15994264
    [Abstract] [Full Text] [Related]

  • 16. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B, Nordmann JP, Sellem E, Chen E, Gold R, Polland W, Williamson W, Buchholz P, Walt JG, Groleau D, Curry A, Evans SJ.
    Acta Ophthalmol Scand; 2006 Feb 01; 84(1):74-83. PubMed ID: 16445443
    [Abstract] [Full Text] [Related]

  • 17. Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma.
    van Agthoven M, Kramer MH, Sonneveld P, van der Hem KG, Huijgens PC, Wijermans PW, Kluin-Nelemans HC, Schaafsma MR, Biesma DH, Mattijssen V, Uyl-de Groot CA, Hagenbeek A.
    Haematologica; 2005 Oct 01; 90(10):1422-32. PubMed ID: 16219580
    [Abstract] [Full Text] [Related]

  • 18. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.
    J Drugs Dermatol; 2008 Jan 01; 7(1):41-9. PubMed ID: 18246697
    [Abstract] [Full Text] [Related]

  • 19. Resource use and costs associated with different states of breast cancer.
    Lidgren M, Wilking N, Jönsson B, Rehnberg C.
    Int J Technol Assess Health Care; 2007 Jan 01; 23(2):223-31. PubMed ID: 17493308
    [Abstract] [Full Text] [Related]

  • 20. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ, Scuffham PA, McCollam PL, Newby DE.
    Curr Med Res Opin; 2007 Mar 01; 23(3):495-503. PubMed ID: 17355731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.